Literature DB >> 29370716

Helios: History and Anatomy of a Successful In-House Enterprise High-Throughput Screening and Profiling Data Analysis System.

Hanspeter Gubler1, Nicholas Clare1, Laurent Galafassi1, Uwe Geissler1,2, Michel Girod1, Guy Herr1.   

Abstract

We describe the main characteristics of the Novartis Helios data analysis software system (Novartis, Basel, Switzerland) for plate-based screening and profiling assays, which was designed and built about 11 years ago. It has been in productive use for more than 10 years and is one of the important standard software applications running for a large user community at all Novartis Institutes for BioMedical Research sites globally. A high degree of automation is reached by embedding the data analysis capabilities into a software ecosystem that deals with the management of samples, plates, and result data files, including automated data loading. The application provides a series of analytical procedures, ranging from very simple to advanced, which can easily be assembled by users in very flexible ways. This also includes the automatic derivation of a large set of quality control (QC) characteristics at every step. Any of the raw, intermediate, and final results and QC-relevant quantities can be easily explored through linked visualizations. Links to global assay metadata management, data warehouses, and an electronic lab notebook system are in place. Automated transfer of relevant data to data warehouses and electronic lab notebook systems are also implemented.

Entities:  

Keywords:  advanced dose-response curve analysis; advanced plate data analysis; data quality control; high-throughput screening; screening data analysis software

Mesh:

Year:  2018        PMID: 29370716     DOI: 10.1177/2472555217752140

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  6 in total

1.  Identification and validation of selective deubiquitinase inhibitors.

Authors:  Anthony C Varca; Dominick Casalena; Wai Cheung Chan; Bin Hu; Robert S Magin; Rebekka M Roberts; Xiaoxi Liu; He Zhu; Hyuk-Soo Seo; Sirano Dhe-Paganon; Jarrod A Marto; Douglas Auld; Sara J Buhrlage
Journal:  Cell Chem Biol       Date:  2021-06-14       Impact factor: 9.039

2.  Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.

Authors:  Benjamin R Taft; Fumiaki Yokokawa; Tom Kirrane; Anne-Catherine Mata; Richard Huang; Nicole Blaquiere; Grace Waldron; Bin Zou; Oliver Simon; Subramanyam Vankadara; Wai Ling Chan; Mei Ding; Sandra Sim; Judith Straimer; Armand Guiguemde; Suresh B Lakshminarayana; Jay Prakash Jain; Christophe Bodenreider; Christopher Thompson; Christian Lanshoeft; Wei Shu; Eric Fang; Jafri Qumber; Katherine Chan; Luying Pei; Yen-Liang Chen; Hanna Schulz; Jessie Lim; Siti Nurdiana Abas; Xiaoman Ang; Yugang Liu; Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Francisco Javier Gamo; Benigno Crespo-Fernandez; Philip J Rosenthal; Roland A Cooper; Patrick Tumwebaze; Anna Caroline Campos Aguiar; Brice Campo; Simon Campbell; Jürgen Wagner; Thierry T Diagana; Christopher Sarko
Journal:  J Med Chem       Date:  2022-03-01       Impact factor: 8.039

3.  Gene-signature-derived IC50s/EC50s reflect the potency of causative upstream targets and downstream phenotypes.

Authors:  Steffen Renner; Christian Bergsdorf; Rochdi Bouhelal; Magdalena Koziczak-Holbro; Andrea Marco Amati; Valerie Techer-Etienne; Ludivine Flotte; Nicole Reymann; Karen Kapur; Sebastian Hoersch; Edward James Oakeley; Ansgar Schuffenhauer; Hanspeter Gubler; Eugen Lounkine; Pierre Farmer
Journal:  Sci Rep       Date:  2020-06-15       Impact factor: 4.379

4.  Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

Authors:  Yue Fu; David Estoppey; Silvio Roggo; Dominik Pistorius; Florian Fuchs; Christian Studer; Ashraf S Ibrahim; Thomas Aust; Frederic Grandjean; Manuel Mihalic; Klaus Memmert; Vivian Prindle; Etienne Richard; Ralph Riedl; Sven Schuierer; Eric Weber; Jürg Hunziker; Frank Petersen; Jianshi Tao; Dominic Hoepfner
Journal:  Nat Commun       Date:  2020-07-07       Impact factor: 14.919

5.  High-Throughput Screen for Inhibitors of Klebsiella pneumoniae Virulence Using a Tetrahymena pyriformis Co-Culture Surrogate Host Model.

Authors:  Angela L Woods; David Parker; Meir M Glick; Yunshan Peng; Francois Lenoir; Evan Mulligan; Vincent Yu; Grazia Piizzi; Troy Lister; Maria-Dawn Lilly; JoAnn Dzink-Fox; Johanna M Jansen; Neil S Ryder; Charles R Dean; Thomas M Smith
Journal:  ACS Omega       Date:  2022-02-01

6.  Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assay.

Authors:  Anthony C Varca; Dominick Casalena; Douglas Auld; Sara J Buhrlage
Journal:  STAR Protoc       Date:  2021-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.